chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Aspiration pleural cavity, Back pain, Bronchitis bacterial, COVID-19, Chronic obstructive pulmonary disease
Clinical narrative: Narrative: 64 YOM with history of advanced COPD, chronic hypoxic respiratory failure on home 02 @2L/min, Lung CA with mets s/p resection and chemotherapy and Lymphoma, now in remission. He also has malignant rt pleural effusion s/p thoracentesis 5/26/21 with 1.8L of exudative fluid removed. He comes tonight with SOB worse over several days and pain the Rt lumbar area. No fever or chills, no nausea or vomiting. Say he has been doing better since ED discharge until last PM when SOB worsened, started to use increasing amount of 02 supplement without improvement. He also admits he has been having worsening cough productive of greenish yellow sputum. Was in the ED on 6/9/21 and discharged with tapering dose prednisone. He became hypoxic to 80's in ED and CTA chest was done but negative for PE and stable with his chronic issues including mets and Rt sided effusion (Less). He improved with SVN treatment, IV Decadron. COVID-19 testing is positive and admission requested but did complete his Pfizer vaccine with second dose on 2/26/2021. Admitted to hospital with COPS exacerbation, acute on chronic hypoxic respiratory failure. Acute bacterial bronchitis. Patient's symptoms improved after treatment with corticosteroids, antibiotics, and other supportive therapy.
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram thorax abnormal, Condition aggravated, Dyspnoea, Hypoxia, Malignant pleural effusion
Clinical narrative: Narrative: 64 YOM with history of advanced COPD, chronic hypoxic respiratory failure on home 02 @2L/min, Lung CA with mets s/p resection and chemotherapy and Lymphoma, now in remission. He also has malignant rt pleural effusion s/p thoracentesis 5/26/21 with 1.8L of exudative fluid removed. He comes tonight with SOB worse over several days and pain the Rt lumbar area. No fever or chills, no nausea or vomiting. Say he has been doing better since ED discharge until last PM when SOB worsened, started to use increasing amount of 02 supplement without improvement. He also admits he has been having worsening cough productive of greenish yellow sputum. Was in the ED on 6/9/21 and discharged with tapering dose prednisone. He became hypoxic to 80's in ED and CTA chest was done but negative for PE and stable with his chronic issues including mets and Rt sided effusion (Less). He improved with SVN treatment, IV Decadron. COVID-19 testing is positive and admission requested but did complete his Pfizer vaccine with second dose on 2/26/2021. Admitted to hospital with COPS exacerbation, acute on chronic hypoxic respiratory failure. Acute bacterial bronchitis. Patient's symptoms improved after treatment with corticosteroids, antibiotics, and other supportive therapy.
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Productive cough, Respiratory failure, SARS-CoV-2 test positive, Sputum discoloured
Clinical narrative: Narrative: 64 YOM with history of advanced COPD, chronic hypoxic respiratory failure on home 02 @2L/min, Lung CA with mets s/p resection and chemotherapy and Lymphoma, now in remission. He also has malignant rt pleural effusion s/p thoracentesis 5/26/21 with 1.8L of exudative fluid removed. He comes tonight with SOB worse over several days and pain the Rt lumbar area. No fever or chills, no nausea or vomiting. Say he has been doing better since ED discharge until last PM when SOB worsened, started to use increasing amount of 02 supplement without improvement. He also admits he has been having worsening cough productive of greenish yellow sputum. Was in the ED on 6/9/21 and discharged with tapering dose prednisone. He became hypoxic to 80's in ED and CTA chest was done but negative for PE and stable with his chronic issues including mets and Rt sided effusion (Less). He improved with SVN treatment, IV Decadron. COVID-19 testing is positive and admission requested but did complete his Pfizer vaccine with second dose on 2/26/2021. Admitted to hospital with COPS exacerbation, acute on chronic hypoxic respiratory failure. Acute bacterial bronchitis. Patient's symptoms improved after treatment with corticosteroids, antibiotics, and other supportive therapy.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Epistaxis
Clinical narrative: any:  Narrative: Received his both Moderna Covid vaccines. First dose on 2/5/21 he had no reaction. Second dose was on 3/5/21/ On 3/6 he developed a nose bleed that lasted approx. 40 minutes. He did not require any kind of medical intervention nor was he evaluated at the ER. He reports having one more episode of bleeding since then, again minor requiring no medical attention, No other side affects reported. .
Age: 68.0
Sex: M
Vaccine: PPV
Symptoms: Erythema, Headache, Swelling
Clinical narrative: Narrative:  Localized redness and swelling with the  pneumococcal 23 vaccine. Patient also developed a headache.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Injection site warmth
Clinical narrative: Narrative: Pt states that he received his 2nd Covid injection from the VA yesterday. Today he is experiencing extreme fatigue, dizziness, & an unusual hot feeling from his skin at the injection site.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Narrative: Pt states that he recently received his first Covid injection & states that he is very fatigued all the time.
Age: 93.0
Sex: U
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  A 92yo male with PMH of Dyslipidemia, HTN, CAD, OA, CHD, Rotator Cuff Tear, Sensorineural Hearing Loss He received Pfizer Covid-19 vaccine per policy and protocol First dose on January 14, 2021 and the second dose on February 4, 2021 No ADE reported or documented System showed Patient passed away on March 15, 2021 - no other documentation
Age: 30.0
Sex: M
Vaccine: TD
Symptoms: Hyperhidrosis, Immunisation reaction, Injection site reaction, Mydriasis, Pallor
Clinical narrative: Narrative:  Injection reaction. Pale, diaphoretic, pupils dilated, short episode of  seizure like activity (per PCP) following receipt of both Tdap and Pneumovax.  Patient had tetanus in past. Provider suspects reaction related to Pneumovax. EMS  transferred patient to local ED. Discharged to home from ED with diagnosis of  vasovagal episode.
Age: 30.0
Sex: M
Vaccine: TD
Symptoms: Presyncope, Seizure like phenomena
Clinical narrative: Narrative:  Injection reaction. Pale, diaphoretic, pupils dilated, short episode of  seizure like activity (per PCP) following receipt of both Tdap and Pneumovax.  Patient had tetanus in past. Provider suspects reaction related to Pneumovax. EMS  transferred patient to local ED. Discharged to home from ED with diagnosis of  vasovagal episode.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative: A 73yo male , received Pfizer Covid- 19 vaccine per policy and protocol First shot February 18. 2021 and the second shot on March 18th, 2021 No ADE was reported.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Dyspnoea
Clinical narrative: Narrative:  A 71yo male with PMH of coronary Bypass surgery, Chronic Periodontitis, Coronary Artery Disease, Hypertension, Hyperlipidemia and Adult Hydrocele Received Janssen Covid - 19 vaccine 0.5ml In the right Deltoid per policy and protocol, on March 20, 2021 No ADR was reported Per Physicians April 14, 2021 documentation, the patient was hospitalized for SOB and under Hospice Care @ Hospice Patient passed away on April of 2021 cause of death not specified
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Breath sounds abnormal, Bundle branch block right, Dizziness, Electrocardiogram abnormal, Pain
Clinical narrative: Narrative:  SUBJECTIVE: The pt reported feeling sharp pain at L side, mid clavicular, deep to costal edge. He reports onset shortly after receiving the COVID-19 vaccine booster (1305hrs). He denies HX of heart conditions but has had stomach ulcers. He has never had this feeling at this location before. He reports just getting discharged from the hospital for blood clots in his neck and  lower legs. He has not eaten since yesterday. Additionally, he reported light headed/dizziness when standing. He reports this symptom is common for him, although it goes away a little quicker. He feels the need to take deeper breaths but is not SOB (rate is not increasing, he does not require a position change, and he is speaking in full sentences with a single breath). OBJECTIVE: The pt ambulated to the EKG room steadily without loss of balance. He has no s/s of distress or SOB. He is speaking in full, logical sentences without pausing for breath. ASSESSMENT: Skin is pink, warm, and a little damp on legs. Stroke assessment was negative. Heart sounds S1 and S2 were audible and regular without additional sounds. Lung sounds were dim but clear. Abdominal sounds were regular in all 4 quadrants. EKG indicated NSR with piossible L atrial enlargement and incomplete RBBB. PLAN: Per the PA- The pt was given an oatmeal cookie with pecans and cranberries and water. He was monitored by an RN in the lobby while waiting to determine if he needed to go to the ER. The RN reassessed and it was decided that he should go to the ER. EMS was called and the pt was picked up shortly after and brought to local ER.
Age: 99.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac failure congestive, Condition aggravated, Death, Ejection fraction decreased
Clinical narrative: Narrative: hospitalized for CHF exacerbation (h/o CHF with EF 20%) on 2/2/21; received second dose after discharge; died 4/14 from CHF likely
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Induration
Clinical narrative: Narrative: Pt is a 74 year old male with PMH of HTN and Afib. He received COVID-19 vaccines (Moderna) 3/23/21 and 4/20/21 at the facility. He reported to PCP on 12/27/21 that he got his COVID-19 booster (Moderna) 12/20/21 at facility and experienced erythema and induration locally encompassing entire deltoid (which deltoid not documented) and surrounding tissue.
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary mass
Clinical narrative: lump under right armpit Narrative:
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Unresponsive to stimuli
Clinical narrative: Narrative:  A 75yo male with PMH of Homelessness, Glaucoma, Diabetic retinopathy, DM, HTN, Insomnia, Impotence, Asthma, COPD, Hepatitis, Multiple Nodule of Lung Received first Pfizer Covid-19 Vaccine per policy and protocol, on January 19, 2021 The second Covid- 19 Vaccine per policy and protocol, on January 19, 2021 The second Covid- 19 vaccine shot on February 9, 2021 No ADE was reported Per March 31, 2021 Diabetic Ed, Nurse Tele visit documentation, the patient's niece reported "he was found unresponsive and pronounced dead on March 22, 2021"
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: Narrative: Patient received COVID-19 vaccination on 4/1/2021. Patient presented to the ED with chest pain. Cardiac work up was negative for acute cardiac or pulmonary emergency and patient was discharged.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash
Clinical narrative: Narrative: Patient received first COVID-19vaccine on 1/27/2021 outside of the Facility. Patient reported tiny bumps on both her lower legs along with slight itchiness and erythema four days after vaccination. Patient also noticed similar but larger bumps on her arms which were not itchy. Patient denied tongue swelling, throat closure, fever, chills, flu-like symptoms, cough, SOB, chest pain, and joint pains. Patient was instructed to take loratadine or diphenhydramine as needed for itching. On 2/23/2021, patient reported that skin rash has resolved on its own after lasting for one week.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Atelectasis, Back pain, Basophil percentage increased, Chest X-ray abnormal
Clinical narrative: Narrative:  64 year old male with PMH of adenocarcinoma of the lungs, multiple lung nodules, HTN, stenosis of liver, BPH, GERD received second dose of COVID-19 vaccine (Moderna) on 4/8/21. On 4/16/21 he called the hospital with complaint of new upper back pain, cough with yellow mucus. He stated that he initially had a fever the day of the vaccine, but was afebrile that morning. Later the same day he reported to the ER with generalized weakness, cough and pain with breathing. Denied nausea/vomiting. BP: 123/75, HR: 62, RR: 16, Pulse Ox: 99, Temp: 98.1F. Notable labs included Eosinophils 5.5% (up from 3.3% in February) Basophils 1.3% (up from 0.7% in February). ED treatment plan noted that ketorolac injection improved symptoms, however no other documentation to show ketorolac was actually administered, so unclear if this was given. Discharged home same day. Follow up messaging with PC later that month and clinic visit 5/7/21 appears the symptoms resolved.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Eosinophil percentage increased, Lung opacity, Painful respiration, Productive cough, Pulmonary fibrosis
Clinical narrative: Narrative:  64 year old male with PMH of adenocarcinoma of the lungs, multiple lung nodules, HTN, stenosis of liver, BPH, GERD received second dose of COVID-19 vaccine (Moderna) on 4/8/21. On 4/16/21 he called the hospital with complaint of new upper back pain, cough with yellow mucus. He stated that he initially had a fever the day of the vaccine, but was afebrile that morning. Later the same day he reported to the ER with generalized weakness, cough and pain with breathing. Denied nausea/vomiting. BP: 123/75, HR: 62, RR: 16, Pulse Ox: 99, Temp: 98.1F. Notable labs included Eosinophils 5.5% (up from 3.3% in February) Basophils 1.3% (up from 0.7% in February). ED treatment plan noted that ketorolac injection improved symptoms, however no other documentation to show ketorolac was actually administered, so unclear if this was given. Discharged home same day. Follow up messaging with PC later that month and clinic visit 5/7/21 appears the symptoms resolved.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Secretion discharge
Clinical narrative: Narrative:  64 year old male with PMH of adenocarcinoma of the lungs, multiple lung nodules, HTN, stenosis of liver, BPH, GERD received second dose of COVID-19 vaccine (Moderna) on 4/8/21. On 4/16/21 he called the hospital with complaint of new upper back pain, cough with yellow mucus. He stated that he initially had a fever the day of the vaccine, but was afebrile that morning. Later the same day he reported to the ER with generalized weakness, cough and pain with breathing. Denied nausea/vomiting. BP: 123/75, HR: 62, RR: 16, Pulse Ox: 99, Temp: 98.1F. Notable labs included Eosinophils 5.5% (up from 3.3% in February) Basophils 1.3% (up from 0.7% in February). ED treatment plan noted that ketorolac injection improved symptoms, however no other documentation to show ketorolac was actually administered, so unclear if this was given. Discharged home same day. Follow up messaging with PC later that month and clinic visit 5/7/21 appears the symptoms resolved.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Malaise, Myalgia, Nephropathy
Clinical narrative: Narrative:  Patient with history of cardiac transplant on tacrolimus/mycophenolate. Received Moderna vaccine x 3 (1st dose 02/08/2021 (0.5 mL), 2nd dose: 03/08/2021 (0.5 mL), 3rd dose: 09/13/2021 (0.5 mL)). He was admitted with mild COVID symptoms including muscle aches and fatigue. He was admitted and treated with dexamethasone 6 mg during admission. Remdesivir was deferred due to renal disease. He complete 3 days of dexamethasone before being discharged.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: Narrative:  A 70yo female with PMH of Bilateral Knee Pain She received  Pfizer COVID - 19 vaccine per policy and protocol first shot on February 6, 20221 and the second shot February 27, 2021 No adverse Event reported
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Injection site pain, Myalgia, Pyrexia
Clinical narrative: Myalgia, Fever,  INJECTION SITE PAIN, FEVER, MUSCLE ACHES, JOINT PAIN, FEVER  Narrative:
Age: 96.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Coronary artery disease, Death, Diabetes mellitus, Terminal state
Clinical narrative: Narrative:  Patient is a 95 yo bed bound M w/ significant PMH: Hx of cognitive impairment, migraines/ giant cell arteritis on daily low dose prednisone--followed by rheum, glaucoma, CAD s/p CABG (2013 at hospital) on ASA, hypertension, hyperlipidemia, diabetes (on pioglitazone and glipizide), chronic diabetic foot ulcers s/p right second toe amputation (11/12/19, 9/10/19)--followed by podiatry, and history of falls. DNR/DNI status. He was discharged from hospice in 12/2020 (terminal diagnosis of end stage coronary artery disease; end stage diabetes). Patient received his 1st dose of the COVID-19 vaccine on 5/26/2021 and 2nd dose on 6/16/2021 without complications. No status changes noted during RNP's 6/18/2021 visit or reported by son during 6/20/21 visit. Patient died on 6/23/21 at 11:09am. Per RNP and supervising MD, clinical presentation was most consistent with terminal diagnosis of end state coronary artery disease and end stage diabetes than an adverse effect of the COVID-19 vaccination series. Reporting given proximity of the patient's death and vaccine per EUA requirements.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Atrial flutter, Atrioventricular block, Electrocardiogram abnormal, Tachycardia
Clinical narrative: Narrative: Pt presented with tachycardia with n/v upon receiving his second dose of the COVID19 vaccine. Physician assessment upon presentation to ED states "77 yr old male who presents in atrial flutter/atrial fibrillation after receiving COVID-19 vaccine". Pt was found to have Aflutter with 2:1 AV block from ECG and physician's plan states that "while symptoms started after receiving a second dose of COVID-19 vaccine patient has no evidence of anaphylaxis including respiratory symptoms, difficulty breathing, no rash or hives or other cutaneous symptoms". Pt was admitted for cardiology and monitoring.
Age: 75.0
Sex: M
Vaccine: FLUA4
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Anaphylactic reaction, Chest X-ray abnormal, Cough, Dysphagia, Dyspnoea
Clinical narrative: Narrative: As per ED note, 6/17/2021: 48 year old MALE presents with: Chief complaint of shortness of breath and persistent cough. Patient states that he took his second dose of Pfizer vaccine yesterday and late afternoon and then when he got home he started experiencing shortness of breath and persistent cough he states that he feels that he has a feeling of something inside his throat. Patient states that he has been having trouble swallowing but he has never attempted to eat anything since yesterday because of cough and discomfort in his throat. Patient denies any history of allergies he denies having any allergic reaction with his first dose of the vaccine. Patient does admit that he has G6PD deficiency. HEENT he denies any nausea or vomiting or any diarrhea or chest pain. MEDICAL DECISION MAKING: We'll order CBC CMP as well as chest x-ray will also give 125 mg of Solu-Medrol and 25 mg of Benadryl IV. We'll consult ENT to make sure there is no swelling or edema in the posterior oropharynx. Patient has been evaluated very ENT and there are no evidence of obstruction or edema in the posterior oropharynx Lab(s) interpretation: WBC 16.12, CMP wnl, rest of WBC wnl EKG: NSR with HR 96 BPM and no acute ST or T wave changes Meds: IV Solu-Medrol 125 mg, IV Benadryl 25 mg, Lasix 20 mg IV Radiology: XR Chest: Subtle findings suggesting central pulmonary vascular congestion and nonspecific hazy infrahilar opacities which could relate to interstitial edema or nonconsolidating pneumonia. Constellation of these findings could relate to fluid overload or congestive heart failure. Response to treatment: Able Final Plan: Patient was evaluated by ENT and recommendations admit patient to stepdown for continuous monitoring the airway and complete a treatment of 3 doses of steroids. After ENT evaluation patient does not appear to have any posterior oropharynx edema or swelling. His chest x-ray showed mild vascular congestion patient was given 1 dose of Lasix 20 mg IV. Final Diagnosis: Anaphylaxis due to COVID vaccine
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram normal, Immunisation reaction, Lung opacity, Metabolic function test normal, Oropharyngeal discomfort
Clinical narrative: Narrative: As per ED note, 6/17/2021: 48 year old MALE presents with: Chief complaint of shortness of breath and persistent cough. Patient states that he took his second dose of Pfizer vaccine yesterday and late afternoon and then when he got home he started experiencing shortness of breath and persistent cough he states that he feels that he has a feeling of something inside his throat. Patient states that he has been having trouble swallowing but he has never attempted to eat anything since yesterday because of cough and discomfort in his throat. Patient denies any history of allergies he denies having any allergic reaction with his first dose of the vaccine. Patient does admit that he has G6PD deficiency. HEENT he denies any nausea or vomiting or any diarrhea or chest pain. MEDICAL DECISION MAKING: We'll order CBC CMP as well as chest x-ray will also give 125 mg of Solu-Medrol and 25 mg of Benadryl IV. We'll consult ENT to make sure there is no swelling or edema in the posterior oropharynx. Patient has been evaluated very ENT and there are no evidence of obstruction or edema in the posterior oropharynx Lab(s) interpretation: WBC 16.12, CMP wnl, rest of WBC wnl EKG: NSR with HR 96 BPM and no acute ST or T wave changes Meds: IV Solu-Medrol 125 mg, IV Benadryl 25 mg, Lasix 20 mg IV Radiology: XR Chest: Subtle findings suggesting central pulmonary vascular congestion and nonspecific hazy infrahilar opacities which could relate to interstitial edema or nonconsolidating pneumonia. Constellation of these findings could relate to fluid overload or congestive heart failure. Response to treatment: Able Final Plan: Patient was evaluated by ENT and recommendations admit patient to stepdown for continuous monitoring the airway and complete a treatment of 3 doses of steroids. After ENT evaluation patient does not appear to have any posterior oropharynx edema or swelling. His chest x-ray showed mild vascular congestion patient was given 1 dose of Lasix 20 mg IV. Final Diagnosis: Anaphylaxis due to COVID vaccine
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary congestion, Sensation of foreign body, Sinus rhythm, White blood cell count increased
Clinical narrative: Narrative: As per ED note, 6/17/2021: 48 year old MALE presents with: Chief complaint of shortness of breath and persistent cough. Patient states that he took his second dose of Pfizer vaccine yesterday and late afternoon and then when he got home he started experiencing shortness of breath and persistent cough he states that he feels that he has a feeling of something inside his throat. Patient states that he has been having trouble swallowing but he has never attempted to eat anything since yesterday because of cough and discomfort in his throat. Patient denies any history of allergies he denies having any allergic reaction with his first dose of the vaccine. Patient does admit that he has G6PD deficiency. HEENT he denies any nausea or vomiting or any diarrhea or chest pain. MEDICAL DECISION MAKING: We'll order CBC CMP as well as chest x-ray will also give 125 mg of Solu-Medrol and 25 mg of Benadryl IV. We'll consult ENT to make sure there is no swelling or edema in the posterior oropharynx. Patient has been evaluated very ENT and there are no evidence of obstruction or edema in the posterior oropharynx Lab(s) interpretation: WBC 16.12, CMP wnl, rest of WBC wnl EKG: NSR with HR 96 BPM and no acute ST or T wave changes Meds: IV Solu-Medrol 125 mg, IV Benadryl 25 mg, Lasix 20 mg IV Radiology: XR Chest: Subtle findings suggesting central pulmonary vascular congestion and nonspecific hazy infrahilar opacities which could relate to interstitial edema or nonconsolidating pneumonia. Constellation of these findings could relate to fluid overload or congestive heart failure. Response to treatment: Able Final Plan: Patient was evaluated by ENT and recommendations admit patient to stepdown for continuous monitoring the airway and complete a treatment of 3 doses of steroids. After ENT evaluation patient does not appear to have any posterior oropharynx edema or swelling. His chest x-ray showed mild vascular congestion patient was given 1 dose of Lasix 20 mg IV. Final Diagnosis: Anaphylaxis due to COVID vaccine
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Anaphylactic reaction, Dysphagia, Lethargy, Oropharyngeal pain, Pain
Clinical narrative: Narrative:  Per RN: "Patient came in on 6/15/21 to the clinic reporting 60+ medication and food allergies and asking for the Janssen vaccine. Patient has had anaphylactic reactions to yellow jacket stings and a typhoid vaccine in the past, but received the flu and pneumonia vaccine without incident. After checking ingredients in the typhoid vaccine and discussing the case with a RN, decision was made to allow patient to receive vaccine. Pt stated he understood the risk, and he and his wife were prepared with their own Benadryl and epipen. Janssen vaccine given at 0915, at 0925, patient said he was itchy and took some of his own benadryl, 25 mg. Pt was offered clinic benadryl, but declined. At 0932, patient reported difficulty swallowing and promptly administered his own epipen in left thigh. Emergency medical response was called at this ime and arrived within 1 minute. Vitals were taken and ambulance was called. Pt had no issues breathing, O2 sats stable, and lung sounds clear. Continued to report difficulty swallowing that was not worsening. Ambulance arrived at 0955 and transported patient to hospital. Per follow up with patient's wife on 6/16, patient was given antihistamines at the ER and stayed for a couple of hours. He is now home with body soreness and lethargy, taking Benadryl q6." Per Primary care f/u on 6/18/21: "Pt arrived w/o severe resp. distress. Pt. had sig upper airway sx. c/w anaphylaxis. Pt treated aggressively with epi and additional meds. Pt had no evid to suggest pharyngeal abscess, no evid. of pneumonia or indication of ptx. no evid arrhythmia on monitor/EKG, no evid by hx or eval to suggest aspirated f.b. Given resp. sx, pt required epi to break sx. quickly. pt. was placed in a room and on a monitor upon arrival. IV started We monitored the patient. During the hour the symptoms began to resolve. The patient had no further respiratory symptoms I discussed possible causes of anaphylaxis. They also understood they should F/U with PCP within 1-2 days, Rx written. Today, spoke to patient over the phone. He is doing well, he continues to take Zyrtec and Zantac. He is no longer taking Benadryl. He denies any swelling. He does continue to have a sore throat but no swelling reported. He was talking in full sentences over the phone with no evidence of respiratory distress. He is doing well otherwise and happy that he at least was able to get the vaccination to limit his risk for developing Covid."
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Respiratory distress, Respiratory symptom
Clinical narrative: Narrative:  Per RN: "Patient came in on 6/15/21 to the clinic reporting 60+ medication and food allergies and asking for the Janssen vaccine. Patient has had anaphylactic reactions to yellow jacket stings and a typhoid vaccine in the past, but received the flu and pneumonia vaccine without incident. After checking ingredients in the typhoid vaccine and discussing the case with a RN, decision was made to allow patient to receive vaccine. Pt stated he understood the risk, and he and his wife were prepared with their own Benadryl and epipen. Janssen vaccine given at 0915, at 0925, patient said he was itchy and took some of his own benadryl, 25 mg. Pt was offered clinic benadryl, but declined. At 0932, patient reported difficulty swallowing and promptly administered his own epipen in left thigh. Emergency medical response was called at this ime and arrived within 1 minute. Vitals were taken and ambulance was called. Pt had no issues breathing, O2 sats stable, and lung sounds clear. Continued to report difficulty swallowing that was not worsening. Ambulance arrived at 0955 and transported patient to hospital. Per follow up with patient's wife on 6/16, patient was given antihistamines at the ER and stayed for a couple of hours. He is now home with body soreness and lethargy, taking Benadryl q6." Per Primary care f/u on 6/18/21: "Pt arrived w/o severe resp. distress. Pt. had sig upper airway sx. c/w anaphylaxis. Pt treated aggressively with epi and additional meds. Pt had no evid to suggest pharyngeal abscess, no evid. of pneumonia or indication of ptx. no evid arrhythmia on monitor/EKG, no evid by hx or eval to suggest aspirated f.b. Given resp. sx, pt required epi to break sx. quickly. pt. was placed in a room and on a monitor upon arrival. IV started We monitored the patient. During the hour the symptoms began to resolve. The patient had no further respiratory symptoms I discussed possible causes of anaphylaxis. They also understood they should F/U with PCP within 1-2 days, Rx written. Today, spoke to patient over the phone. He is doing well, he continues to take Zyrtec and Zantac. He is no longer taking Benadryl. He denies any swelling. He does continue to have a sore throat but no swelling reported. He was talking in full sentences over the phone with no evidence of respiratory distress. He is doing well otherwise and happy that he at least was able to get the vaccination to limit his risk for developing Covid."
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Injection site pain
Clinical narrative: Narrative:  Patient reports that since his 2nd vaccine he has had intermittent L shoulder pain that feels similar to the injection pain he felt on the day of the vaccine.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Adverse reaction, Computerised tomogram head normal, Hypoaesthesia, Musculoskeletal chest pain
Clinical narrative: Narrative:  Presented to hospital for evaluation of adverse reaction involving right posterior neck pain/numbness and right-sided chest wall and abdominal pain/paresthesia after 1st covid vaccine. Went to loval ER and had evaluation including negative CT head per history.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Neck pain, Paraesthesia
Clinical narrative: Narrative:  Presented to hospital for evaluation of adverse reaction involving right posterior neck pain/numbness and right-sided chest wall and abdominal pain/paresthesia after 1st covid vaccine. Went to loval ER and had evaluation including negative CT head per history.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Influenza like illness, Injection site pain, Pyrexia
Clinical narrative: Narrative:  Pt. reports had sore arm at injection site x several days, and mild flu like symptoms x several days following vaccination; felt better, but then felt feverish and had 1 episode of diarrhea on 2/22. no symptoms on 2/23.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation
Clinical narrative: Narrative:  Patient developed atrial fibrillation with RVR. Was hospitalized
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Angiogram pulmonary abnormal, Aspartate aminotransferase increased, Blood chloride decreased, Blood creatine phosphokinase MB increased
Clinical narrative: Narrative:  HPI: Patient presented to the ED on 12/28/2021 with a chief complaint of worsening shortness of breath, fevers, fatigue, and body aches x 3 to 4 days. Of note, he was discharged from hospital on 12/20/2021 following a 6 day admission for bacterial pneumonia. On arrival to our ED, patient waws afebrile, tachycardic (HR 118), tachypneic (RR 25), and hypoxic (SpO2 85% on 3LPM via nasal cannula). Labs in ED revealed leukocytosis (WBC 21.61), hyponatremia (Na 131mmol/L), hypochloremia (Cl 91.6mmol/L), AKI (Scr 1.2mg/dL, baseline = 0.7mg/dL), elevated AST (106 IU/L), elevated CPK (3932), elevated CKMB (20.7), positive d-dimer (GREATER THAN 20), positive lactate (2.8), positive troponin (0.17), and elevated BNP (221.6). EKG was negative for acute changes. CTA chest was negative for PE but did reveal worsening RLL consolidation. Blood cultures were obtained. ABG was attempted unsuccessfully x 4. Patient was given NS x 1L, ondansetron 4mg IVP x1, ceftriaxone 1g IV x 1, acetaminophen 650mg PO x 1, albuterol/ipratropium neb x 1, and methylprednisolone 125mg IVP x 1 in the ED. He was admitted to ICU for further care. Update of Present Illness: SpO2 was stable at 4LPM on admission. Meropenem + doxycycline initiated. ID consulted. Dexamethasone initiated. Remdesivir held due to elevated AST. Patient transferred to Medical COVID Unit on 12/29/2021.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Blood creatine phosphokinase increased, Blood creatinine normal, Blood culture, Blood lactic acid, Blood sodium decreased
Clinical narrative: Narrative:  HPI: Patient presented to the ED on 12/28/2021 with a chief complaint of worsening shortness of breath, fevers, fatigue, and body aches x 3 to 4 days. Of note, he was discharged from hospital on 12/20/2021 following a 6 day admission for bacterial pneumonia. On arrival to our ED, patient waws afebrile, tachycardic (HR 118), tachypneic (RR 25), and hypoxic (SpO2 85% on 3LPM via nasal cannula). Labs in ED revealed leukocytosis (WBC 21.61), hyponatremia (Na 131mmol/L), hypochloremia (Cl 91.6mmol/L), AKI (Scr 1.2mg/dL, baseline = 0.7mg/dL), elevated AST (106 IU/L), elevated CPK (3932), elevated CKMB (20.7), positive d-dimer (GREATER THAN 20), positive lactate (2.8), positive troponin (0.17), and elevated BNP (221.6). EKG was negative for acute changes. CTA chest was negative for PE but did reveal worsening RLL consolidation. Blood cultures were obtained. ABG was attempted unsuccessfully x 4. Patient was given NS x 1L, ondansetron 4mg IVP x1, ceftriaxone 1g IV x 1, acetaminophen 650mg PO x 1, albuterol/ipratropium neb x 1, and methylprednisolone 125mg IVP x 1 in the ED. He was admitted to ICU for further care. Update of Present Illness: SpO2 was stable at 4LPM on admission. Meropenem + doxycycline initiated. ID consulted. Dexamethasone initiated. Remdesivir held due to elevated AST. Patient transferred to Medical COVID Unit on 12/29/2021.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Brain natriuretic peptide increased, Dyspnoea, Electrocardiogram normal, Fatigue, Fibrin D dimer
Clinical narrative: Narrative:  HPI: Patient presented to the ED on 12/28/2021 with a chief complaint of worsening shortness of breath, fevers, fatigue, and body aches x 3 to 4 days. Of note, he was discharged from hospital on 12/20/2021 following a 6 day admission for bacterial pneumonia. On arrival to our ED, patient waws afebrile, tachycardic (HR 118), tachypneic (RR 25), and hypoxic (SpO2 85% on 3LPM via nasal cannula). Labs in ED revealed leukocytosis (WBC 21.61), hyponatremia (Na 131mmol/L), hypochloremia (Cl 91.6mmol/L), AKI (Scr 1.2mg/dL, baseline = 0.7mg/dL), elevated AST (106 IU/L), elevated CPK (3932), elevated CKMB (20.7), positive d-dimer (GREATER THAN 20), positive lactate (2.8), positive troponin (0.17), and elevated BNP (221.6). EKG was negative for acute changes. CTA chest was negative for PE but did reveal worsening RLL consolidation. Blood cultures were obtained. ABG was attempted unsuccessfully x 4. Patient was given NS x 1L, ondansetron 4mg IVP x1, ceftriaxone 1g IV x 1, acetaminophen 650mg PO x 1, albuterol/ipratropium neb x 1, and methylprednisolone 125mg IVP x 1 in the ED. He was admitted to ICU for further care. Update of Present Illness: SpO2 was stable at 4LPM on admission. Meropenem + doxycycline initiated. ID consulted. Dexamethasone initiated. Remdesivir held due to elevated AST. Patient transferred to Medical COVID Unit on 12/29/2021.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Hypochloraemia, Hyponatraemia, Hypoxia, Intensive care, Leukocytosis
Clinical narrative: Narrative:  HPI: Patient presented to the ED on 12/28/2021 with a chief complaint of worsening shortness of breath, fevers, fatigue, and body aches x 3 to 4 days. Of note, he was discharged from hospital on 12/20/2021 following a 6 day admission for bacterial pneumonia. On arrival to our ED, patient waws afebrile, tachycardic (HR 118), tachypneic (RR 25), and hypoxic (SpO2 85% on 3LPM via nasal cannula). Labs in ED revealed leukocytosis (WBC 21.61), hyponatremia (Na 131mmol/L), hypochloremia (Cl 91.6mmol/L), AKI (Scr 1.2mg/dL, baseline = 0.7mg/dL), elevated AST (106 IU/L), elevated CPK (3932), elevated CKMB (20.7), positive d-dimer (GREATER THAN 20), positive lactate (2.8), positive troponin (0.17), and elevated BNP (221.6). EKG was negative for acute changes. CTA chest was negative for PE but did reveal worsening RLL consolidation. Blood cultures were obtained. ABG was attempted unsuccessfully x 4. Patient was given NS x 1L, ondansetron 4mg IVP x1, ceftriaxone 1g IV x 1, acetaminophen 650mg PO x 1, albuterol/ipratropium neb x 1, and methylprednisolone 125mg IVP x 1 in the ED. He was admitted to ICU for further care. Update of Present Illness: SpO2 was stable at 4LPM on admission. Meropenem + doxycycline initiated. ID consulted. Dexamethasone initiated. Remdesivir held due to elevated AST. Patient transferred to Medical COVID Unit on 12/29/2021.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Lung consolidation, Pain, Pneumonia bacterial, Pyrexia, Tachycardia
Clinical narrative: Narrative:  HPI: Patient presented to the ED on 12/28/2021 with a chief complaint of worsening shortness of breath, fevers, fatigue, and body aches x 3 to 4 days. Of note, he was discharged from hospital on 12/20/2021 following a 6 day admission for bacterial pneumonia. On arrival to our ED, patient waws afebrile, tachycardic (HR 118), tachypneic (RR 25), and hypoxic (SpO2 85% on 3LPM via nasal cannula). Labs in ED revealed leukocytosis (WBC 21.61), hyponatremia (Na 131mmol/L), hypochloremia (Cl 91.6mmol/L), AKI (Scr 1.2mg/dL, baseline = 0.7mg/dL), elevated AST (106 IU/L), elevated CPK (3932), elevated CKMB (20.7), positive d-dimer (GREATER THAN 20), positive lactate (2.8), positive troponin (0.17), and elevated BNP (221.6). EKG was negative for acute changes. CTA chest was negative for PE but did reveal worsening RLL consolidation. Blood cultures were obtained. ABG was attempted unsuccessfully x 4. Patient was given NS x 1L, ondansetron 4mg IVP x1, ceftriaxone 1g IV x 1, acetaminophen 650mg PO x 1, albuterol/ipratropium neb x 1, and methylprednisolone 125mg IVP x 1 in the ED. He was admitted to ICU for further care. Update of Present Illness: SpO2 was stable at 4LPM on admission. Meropenem + doxycycline initiated. ID consulted. Dexamethasone initiated. Remdesivir held due to elevated AST. Patient transferred to Medical COVID Unit on 12/29/2021.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Tachypnoea, Troponin increased, White blood cell count increased
Clinical narrative: Narrative:  HPI: Patient presented to the ED on 12/28/2021 with a chief complaint of worsening shortness of breath, fevers, fatigue, and body aches x 3 to 4 days. Of note, he was discharged from hospital on 12/20/2021 following a 6 day admission for bacterial pneumonia. On arrival to our ED, patient waws afebrile, tachycardic (HR 118), tachypneic (RR 25), and hypoxic (SpO2 85% on 3LPM via nasal cannula). Labs in ED revealed leukocytosis (WBC 21.61), hyponatremia (Na 131mmol/L), hypochloremia (Cl 91.6mmol/L), AKI (Scr 1.2mg/dL, baseline = 0.7mg/dL), elevated AST (106 IU/L), elevated CPK (3932), elevated CKMB (20.7), positive d-dimer (GREATER THAN 20), positive lactate (2.8), positive troponin (0.17), and elevated BNP (221.6). EKG was negative for acute changes. CTA chest was negative for PE but did reveal worsening RLL consolidation. Blood cultures were obtained. ABG was attempted unsuccessfully x 4. Patient was given NS x 1L, ondansetron 4mg IVP x1, ceftriaxone 1g IV x 1, acetaminophen 650mg PO x 1, albuterol/ipratropium neb x 1, and methylprednisolone 125mg IVP x 1 in the ED. He was admitted to ICU for further care. Update of Present Illness: SpO2 was stable at 4LPM on admission. Meropenem + doxycycline initiated. ID consulted. Dexamethasone initiated. Remdesivir held due to elevated AST. Patient transferred to Medical COVID Unit on 12/29/2021.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  A 71yo male with PMH of Tobacco use, Cocaine dependence, Alcohol Dependence, Chronic Hepatitis, Seizure Disorder, Cirrhosis of Liver, Herpes Zoster, Benign Essential HTN, solitary Pulmonary Nodules, Primary Malignant Neoplasm of Liver ( Metastatic Cholangiocarcinoma ) and Immediate Transfusion Reaction. He received Pfizer Covid-19 vaccine per Policy and Protocol without complication, on March 18, 2021 No record of second vaccine dose No ADE reported An oncology patient with metastatic Cholangiocarcinoma and on palliative care System showed he passed away on April 11, 2021.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Cough, Dizziness, Headache
Clinical narrative: Headache, Arthralgia, CoughWheeze,  LIGHTHEADNESS, HEADACHE, FEVER,  CHILLS, BODY ACHES, SINUSITIS
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Sinusitis, Wheezing
Clinical narrative: Headache, Arthralgia, CoughWheeze,  LIGHTHEADNESS, HEADACHE, FEVER,  CHILLS, BODY ACHES, SINUSITIS
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Amyotrophic lateral sclerosis, Death
Clinical narrative: Narrative: 66yo pt died during inpatient hospice care on 6/10/2021. Death caused by Amyotrophic Lateral Sclerosis per MD death note. Pt had received covid vaccinations on 2/25/2021 & 4/7/2021. Death appears unrelated to vaccinations.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myeloid leukaemia, Condition aggravated, Death, Disease complication
Clinical narrative: Narrative:  70yo male with a history of acute myeloid leukemia, myelodysplastic/myeloproliferative disease, HLD, diabetes mellitus, and HTN. Died on 06/16/2021 in a hospice care facility. Patient received covid vaccinations on 01/08/21 and 02/05/21. Appears patient died from complications of AML and death does not appear to be related to the covid vaccinations.
Age: 75.0
Sex: M
Vaccine: VARZOS
Symptoms: Rash, Rash pruritic, Refusal of vaccination
Clinical narrative: Narrative:  Patient developed itchy rash on arms and legs at zoster vaccine. Refuses second dose.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness Narrative: Reports dizziness today. Recieved 2 doses of Pfizer > 6 mo ago and booster recieved is moderna
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Lung squamous cell carcinoma stage IV
Clinical narrative: Narrative:  Pt had received vaccines on 1/7/2021 & 2/4/2021. Pt died of stage 4 SCC Lung Cancer during inpatient hospice care on 6/1012021. Appears covid vaccines were unrelated to patient's death.
Age: 96.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Narrative:  Pt received covid vaccines on 12/20/21 & 01/16/2021. Pt was residing in health care rehab facility who transferred him to hospital on 6/7/2021. Pt died at hospital on same day admitted, 6/7/2021. Pt with large problem list in records system: Urinary incontinence A Decrease in appetite A Malnutrition A Seen by palliative care medicine service A CAD - Coronary artery disease A CHF - Congestive heart failure HFrEF 35% A Hyperlipidemia A AF - Atrial fibrillation A Femoral artery thrombosis Onset 05/27/2020 1. Right 2. S/p thromboebolectomy R SFA, popliteal, tibial arteries A Pleural effusion A Gout A Cardiomyopathy Ischemic A History of left cataract extraction A Glaucoma A OA - Osteoarthritis A Cardiac defibrillator in situ ( A Allergic rhinitis A Benign prostatic hypertrophy without outflow Appears death is unrelated to vaccinations.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Antibody test positive, Contusion, Immune thrombocytopenia, Immunoglobulin therapy, Laboratory test abnormal
Clinical narrative: Narrative: Immune Thrombocytopenic Purpura (ITP) associated with Pfizer COVID-19 Vaccine: Patient had received both doses of Pfizer COVID-19 Vaccine (dose #1: 4-12-21; dose #2: 5-3-21). Around May 10, 2021 patient began to notice bruising on her legs bilaterally and also developed numerous bruises on upper quadrant of her abdomen, forearms, and petechiae on her chest. Denied hematochezia, melena, vaginal bleeding, epistaxis, or oral mucosal bleeding. Routine labs noted platelet count of 3,000 (6-14-21). Was admitted to medicine team and given high dose Dexamethasone 40mg IV daily x 4 days and IVIG (1 gm/kg) therapy (2 doses) with prompt resolution of thrombocytopenia (platelet count on day of discharge = 153,000). Platelet Antibody, IgG: positive
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Petechiae, Platelet count decreased
Clinical narrative: Narrative: Immune Thrombocytopenic Purpura (ITP) associated with Pfizer COVID-19 Vaccine: Patient had received both doses of Pfizer COVID-19 Vaccine (dose #1: 4-12-21; dose #2: 5-3-21). Around May 10, 2021 patient began to notice bruising on her legs bilaterally and also developed numerous bruises on upper quadrant of her abdomen, forearms, and petechiae on her chest. Denied hematochezia, melena, vaginal bleeding, epistaxis, or oral mucosal bleeding. Routine labs noted platelet count of 3,000 (6-14-21). Was admitted to medicine team and given high dose Dexamethasone 40mg IV daily x 4 days and IVIG (1 gm/kg) therapy (2 doses) with prompt resolution of thrombocytopenia (platelet count on day of discharge = 153,000). Platelet Antibody, IgG: positive
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Pt had received covid vaccines on 2/26/21 &3/26/21. Pt died at home on 5/16/21. Unclear if pt's death related to the vaccinations. No information provided about the cause of patient's death. Pt medical problems in cprs: Hypertensive disorder Hyperlipidemia Low back pain Hepatitis C without mention of hepatic coma
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Pt receivd covid vaccinations on 1/18/2021 & 2/8/2021 at nursing home facility where pt resided. Pt was transfered to home hospice on 6/4/2021. Pt died at home on 6/9/2021. Pt had history of dementia & unable to care for self. ALso pt had other medical issues listed below: J44.9 Chronic obstructive lung disease (SCT 13645005) N18.6 End-stage renal disease (SCT 46177005) D63.1 Anemia in end stage renal disease (SCT 707324008) M79.605 Pain in left lower limb (SCT 287047008) Z99.3 Dependence on wheelchair (SCT 105503008) I10. Benign essential hypertension (SCT 1201005) R63.0 Anorexia (SCT 79890006) M13.0 Polyarthritis (SCT 416956002) E03.9 Hypothyroidism (SCT 40930008) R69. Aggressive behavior (SCT 61372001) Z51.5 Seen by palliative care service (SCT 441874000) R45.1 Restlessness and agitation (SCT 274647009) R53.83 Malaise and fatigue (SCT 271795006) Likely pt's death soon after admission to hospice unrelated to covid vaccinations.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Death, Neoplasm malignant
Clinical narrative: Narrative: Pt with malignant neoplasm of breast, secondary malignant neoplasms of bone, and lymph nodes. Also hx of depression, gi reflux, vit b6 def, hypocalcemia, CKD stage 3, hypothyroidism, paresthesia, carpal tunnel syndrome, osteopenia, anxiety disorder had received covid vaccines on 3/23/21 & 4/20/21. Pt died on 5/19/2021 likely of cancer diagnosis & death not related to covid vaccines, however no notes regarding details of patient's death